Neurotransmitter transporters are integral membrane proteins responsible for the rapid clearance of signalling molecules from the synaptic cleft and their return to presynaptic terminals.

Traditionally, treatments focused on boosting serotonin levels or other neurotransmitters, resulting in long waiting periods for patients to notice any changes, without any assurance of effectiveness.

Gordon Research Conference neuroscience 2026: Four GRCs are simultaneously underway July 19–24 across three US states and ...

Can fake shopping ‘dopamine sites’ curb my lazy millennial doom-spending? - IN FOCUS: A wave of new platforms promise the ...

A team from the University of Bonn and the Research Center Borstel, Leibniz Lung Center (FZB) has discovered a previously ...

Seizures can race through the brain in seconds, making them difficult to capture in detail. To overcome this challenge, researchers have ...